Search

MediciNova Inc

Открыт

СекторЗдравоохранение

2.48 24

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

1.96

Макс.

2.54

Ключевые показатели

By Trading Economics

Доход

-2.3B

-2.3B

Продажи

271K

458K

Прибыль на акцию

-0.05

Рентабельность продаж

-504,786.678

Сотрудники

6

EBITDA

5.1K

-2.5M

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

+296.04% upside

Дивиденды

By Acuity

Следующий отчет о доходах

10 нояб. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

27M

92M

Предыдущая цена открытия

-21.52

Предыдущая цена закрытия

2.48

Новостные настроения

By Acuity

41%

59%

99 / 339 Рейтинг в Healthcare

MediciNova Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

15 сент. 2026 г., 20:01 UTC

Shares of MediciNova Inc. are higher today amid notable volatility. The stock rebounded after an early dip, reflecting broader market sentiment concerns.

14 сент. 2026 г., 20:03 UTC

MediciNova Inc shares are higher today, continuing a notable advance since Friday. The stock remains near the upper end of its one-month trading range.

11 сент. 2026 г., 20:08 UTC

MediciNova Inc shares are higher today, reflecting strong market momentum since Thursday's close, maintaining a position above the 20-day moving average.

10 сент. 2026 г., 20:03 UTC

MediciNova Inc. shares are lower during Thursday's session, following an early peak. The decline contrasts with four consecutive higher sessions amid broader market volatility.

9 сент. 2026 г., 20:01 UTC

MediciNova Inc shares are higher today, continuing an upward trend since Tuesday's close. The stock remains well above recent averages.

8 сент. 2026 г., 23:01 UTC

MediciNova Inc shares are higher in after-market trading, marking five consecutive sessions of gains. No specific news was identified to explain this movement.

4 сент. 2026 г., 20:07 UTC

MediciNova Inc. shares are higher today, maintaining a positive trend since Thursday's close and remaining above the 20-day moving average.

3 сент. 2026 г., 20:02 UTC

MediciNova Inc is trading higher, reflecting strong buying interest since Wednesday's close. The stock remains near the upper end of its one-month trading range.

28 авг. 2026 г., 20:07 UTC

Shares of MediciNova Inc. are higher today, reflecting positive momentum. The stock is trading well above its 20-day moving average.

27 авг. 2026 г., 20:03 UTC

MediciNova Inc. shares are lower today, continuing a downward trend since Wednesday's close, despite remaining above the 20-day moving average.

26 авг. 2026 г., 19:08 UTC

MediciNova Inc shares are lower today, reflecting significant volatility after three consecutive sessions of gains. No specific news was identified to explain the decline.

25 авг. 2026 г., 19:36 UTC

MediciNova Inc. shares are higher today, supported by a strong performance backdrop and broader market sentiment from lower crude oil prices and declining Treasury yields.

24 авг. 2026 г., 20:02 UTC

MediciNova Inc shares are higher today, continuing a strong upward trend since Friday's close. The stock remains near the upper end of its one-month range.

21 авг. 2026 г., 19:56 UTC

MediciNova Inc's shares are higher today, continuing a positive trend. The stock is trading above its 20-day moving average amid gains in the cryptocurrency sector.

20 авг. 2026 г., 19:16 UTC

MediciNova Inc. shares are lower today, having previously declined significantly before recovering. The price remains above its 20-day moving average.

18 авг. 2026 г., 19:56 UTC

MediciNova Inc shares are higher, reflecting positive market momentum. The stock remains above its 20-day moving average and near the upper end of its one-month range.

17 авг. 2026 г., 19:56 UTC

News

MediciNova shares are higher as the company reported earnings of -$0.05 per share, surpassing estimates and generating $0.46 million in revenue.

13 авг. 2026 г., 19:26 UTC

MediciNova Inc shares are lower amid broader market pressure from rising jobless claims and stabilizing inflation indicators. The stock trades near its one-month range low.

12 авг. 2026 г., 19:56 UTC

MediciNova Inc. shares are trading roughly flat with no specific news identified, remaining near the lower end of their one-month trading range.

11 авг. 2026 г., 20:06 UTC

MediciNova Inc. shares are roughly flat, showing little movement since Monday's close and positioned near the lower end of their one-month trading range.

10 авг. 2026 г., 19:46 UTC

MediciNova Inc shares are lower today, continuing a downward trend since Friday. Broader market sentiment is affected by recent U.S. employment data.

7 авг. 2026 г., 19:46 UTC

MediciNova Inc. shares are higher today, recovering from earlier losses. The stock is trading around the middle of its one-month range.

6 авг. 2026 г., 20:13 UTC

MediciNova Inc shares are higher in after-market trading, reflecting strength since Thursday's close amid rising U.S. Treasury yields and a hawkish Fed outlook.

4 авг. 2026 г., 19:36 UTC

MediciNova Inc. shares are trading roughly flat amid broader market reactions to a decline in U.S. core factory orders and ongoing strength in AI sectors.

3 авг. 2026 г., 20:06 UTC

MediciNova Inc. shares are lower, continuing a decline since Friday's close, despite positive movements in major indices like the S&P 500 and Nasdaq 100.

31 июл. 2026 г., 19:56 UTC

Shares of MediciNova Inc. are lower during Friday's session, following a routine decline after an early high. The stock is below its 20-day moving average.

30 июл. 2026 г., 20:51 UTC

MediciNova Inc's shares are lower in after-market hours, reflecting a broader decline in the Biotechnology sub-sector. The asset is near its one-month trading range low.

29 июл. 2026 г., 20:09 UTC

MediciNova Inc shares are lower today, continuing a decline since Tuesday's close, and remain near their opening low amid broader market trends.

28 июл. 2026 г., 18:46 UTC

MediciNova Inc. shares are trading higher today, remaining above Monday's close despite settling back from earlier gains during the session.

27 июл. 2026 г., 19:06 UTC

MediciNova Inc. shares are lower today, reflecting broader market trends amid a significant decline in crude oil prices following eased geopolitical tensions.

Сравнение c конкурентами

Изменение цены

MediciNova Inc Прогноз

Целевая цена

By TipRanks

296.04% рост

Прогноз на 12 месяцев

Средняя 8 USD  296.04%

Максимум 10 USD

Минимум 6 USD

Основано на мнении 2 аналитиков Wall Street, спрогнозировавших целевые цены для MediciNova Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

2 ratings

2

Покупка

0

Удержание

0

Продажа

Настроения

By Acuity

99 / 339Рейтинг в Здравоохранение

Новостные настроения

Свидетельства восходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании MediciNova Inc

MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological and other disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction, as well as prevention of acute respiratory distress syndrome, and long COVID. The company's product pipeline also includes MN-221 (bedoradrine), a selective beta-2-adrenergic receptor agonist for the treatment of acute exacerbations of asthma; MN-001 (tipelukast), an orally bioavailable small molecule compound to treat fibrotic and other diseases, including nonalcoholic fatty liver disease and idiopathic pulmonary fibrosis; and MN-029 (denibulin), a tubulin binding agent for treating solid tumor cancers. It has license agreements with Kyorin Pharmaceutical Co., Ltd; Angiogene Pharmaceuticals, Ltd.; and Meiji Seika Kaisha, Ltd. The company was incorporated in 2000 and is headquartered in La Jolla, California.
help-icon Live chat